FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:489-490 February 6, 2003 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Muñoz, N. PubMed Citation

It is now clear that virtually all squamous-cell cervical carcinomas contain one of 18 types of human papillomavirus (HPV) DNA, as shown definitively in the article by Muñoz et al. in this issue of the Journal (pages 518–527). Although the observation that HPV DNA is routinely detected in cervical cancers is not proof that it has a causal role, the relative risk of cervical cancer associated with high-risk types of HPV is even higher than the risk of lung cancer associated with smoking. Several oncogenes have been identified in high-risk (oncogenic) types of HPV, and the biologic mechanisms of malignant . . . [Full Text of this Article]

Source Information

From the Department of Pathology, College of Physicians and Surgeons of Columbia University, New York (T.C.W.); and the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md. (M.S.).

This article has been cited by other articles:

• Castle, P. E., Sadorra, M., Lau, T., Aldrich, C., Garcia, F. A. R., Kornegay, J. (2009). Evaluation of a Prototype Real-Time PCR Assay for Carcinogenic Human Papillomavirus (HPV) Detection and Simultaneous HPV Genotype 16 (HPV16) and HPV18 Genotyping. J. Clin. Microbiol. 47: 3344-3347 [Abstract] [Full Text]  
• Castle, P. E., Porras, C., Quint, W. G., Rodriguez, A. C., Schiffman, M., Gravitt, P. E., Gonzalez, P., Katki, H. A., Silva, S., Freer, E., Van Doorn, L.-J., Jimenez, S., Herrero, R., Hildesheim, A., for the CVT Group, (2008). Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods. J. Clin. Microbiol. 46: 3437-3445 [Abstract] [Full Text]  
• De Alba, I., Anton-Culver, H., Hubbell, F. A., Ziogas, A., Hess, J. R., Bracho, A., Arias, C., Manetta, A. (2008). Self-Sampling for Human Papillomavirus in a Community Setting: Feasibility in Hispanic Women. Cancer Epidemiol. Biomarkers Prev. 17: 2163-2168 [Abstract] [Full Text]  
• Castle, P. E. (2008). Invited Commentary: Is Monitoring of Human Papillomavirus Infection for Viral Persistence Ready for Use in Cervical Cancer Screening?. Am J Epidemiol 168: 138-144 [Abstract] [Full Text]  
• Castle, P. E., Gravitt, P. E., Solomon, D., Wheeler, C. M., Schiffman, M. (2008). Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study. J. Clin. Microbiol. 46: 109-117 [Abstract] [Full Text]  
• Sokolova, I., Algeciras-Schimnich, A., Song, M., Sitailo, S., Policht, F., Kipp, B. R., Voss, J. S., Halling, K. C., Ruth, A., King, W., Underwood, D., Brainard, J., Morrison, L. (2007). Chromosomal Biomarkers for Detection of Human Papillomavirus Associated Genomic Instability in Epithelial Cells of Cervical Cytology Specimens. J. Mol. Diagn. 9: 604-611 [Abstract] [Full Text]  
• Castle, P. E., Dockter, J., Giachetti, C., Garcia, F. A.R., McCormick, M. K., Mitchell, A. L., Holladay, E. B., Kolk, D. P. (2007). A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer. Clin. Cancer Res. 13: 2599-2605 [Abstract] [Full Text]  
• Castle, P. E., Sadorra, M., Garcia, F. A.R., Cullen, A. P., Lorincz, A. T., Mitchell, A. L., Whitby, D., Chuke, R., Kornegay, J. R. (2007). Mouthwash as a Low-Cost and Safe Specimen Transport Medium for Human Papillomavirus DNA Testing of Cervicovaginal Specimens. Cancer Epidemiol. Biomarkers Prev. 16: 840-843 [Abstract] [Full Text]  
• Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., Harper, D. M., Kinney, W., Moscicki, A.-B., Noller, K. L., Wheeler, C. M., Ades, T., Andrews, K. S., Doroshenk, M. K., Kahn, K. G., Schmidt, C., Shafey, O., Smith, R. A., Partridge, E. E., (for The Gynecologic Cancer Advisory Group), , Garcia, F. (2007). American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. CA Cancer J Clin 57: 7-28 [Abstract] [Full Text]  
• Sandri, M. T., Lentati, P., Benini, E., Dell'Orto, P., Zorzino, L., Carozzi, F. M., Maisonneuve, P., Passerini, R., Salvatici, M., Casadio, C., Boveri, S., Sideri, M. (2006). Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples.. J. Clin. Microbiol. 44: 2141-2146 [Abstract] [Full Text]  
• Schiffman, M., Castle, P. E (2006). When to test women for human papillomavirus. BMJ 332: 61-62 [Full Text]  
• Sawaya, G. F. (2005). A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance. JAMA 294: 2210-2218 [Full Text]  
• Lau, S., Franco, E. L. (2005). Management of low-grade cervical lesions in young women. CMAJ 173: 771-774 [Full Text]  
• Schiffman, M., Castle, P. E., Solomon, D., Stoler, M., Wheeler, C. (2005). RESPONSE: Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests. JNCI J Natl Cancer Inst 97: 939-941 [Full Text]  
• McIntyre-Seltman, K., Castle, P. E., Guido, R., Schiffman, M., Wheeler, C. M., for The ALTS Group, (2005). Smoking Is a Risk Factor for Cervical Intraepithelial Neoplasia Grade 3 among Oncogenic Human Papillomavirus DNA-Positive Women with Equivocal or Mildly Abnormal Cytology. Cancer Epidemiol. Biomarkers Prev. 14: 1165-1170 [Abstract] [Full Text]  
• Schiffman, M., Khan, M. J., Solomon, D., Herrero, R., Wacholder, S., Hildesheim, A., Rodriguez, A. C., Bratti, M. C., Wheeler, C. M., Burk, R. D., For the PEG Group and the ALTS Group, (2005). A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests. JNCI J Natl Cancer Inst 97: 147-150 [Abstract] [Full Text]  
• Castle, P. E., Phillips, T. M., Hildesheim, A., Herrero, R., Bratti, M. C., Rodriguez, A. C., Morera, L. A., Pfeiffer, R., Hutchinson, M. L., Pinto, L. A., Schiffman, M. (2003). Immune Profiling of Plasma and Cervical Secretions Using Recycling Immunoaffinity Chromatography. Cancer Epidemiol. Biomarkers Prev. 12: 1449-1456 [Abstract] [Full Text]  
• Sawaya, G. F., McConnell, K. J., Kulasingam, S. L., Lawson, H. W., Kerlikowske, K., Melnikow, J., Lee, N. C., Gildengorin, G., Myers, E. R., Washington, A. E. (2003). Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings. NEJM 349: 1501-1509 [Abstract] [Full Text]  
• Sherman, M. E., Wang, S. S., Wheeler, C. M., Rich, L., Gravitt, P. E., Tarone, R., Schiffman, M. (2003). Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions. Cancer Epidemiol. Biomarkers Prev. 12: 1038-1044 [Abstract] [Full Text]  
• Siegelman, E. S. (2003). Invited Commentary. RadioGraphics 23: 981-981 [Full Text]  
• (2003). Newly Identified HPV Types: How Will They Affect Cervical Cancer Screening?. JWatch Women's Health 2003: 8-8 [Full Text]  
• (2003). Unraveling the Epidemiology of HPV Types and Cervical Cancer. JWatch Infect. Diseases 2003: 6-6 [Full Text]